CSF3 and neuroblastoma: Currently, large quantities of G-CSF are being used to treat neuroblastoma patients to ensure bone marrow recovery after several cycles of myelosuppressive chemotherapy, although sufficient evidence has not yet been obtained to confirm that such therapy improves overall patient survival [131].